Do Hedge Funds Love Silver Wheaton Corp. (USA) (SLW)?

Page 2 of 2

Since Silver Wheaton Corp. (USA) (NYSE:SLW) has faced bearish sentiment from the smart money, logic holds that there lies a certain “tier” of hedgies that decided to sell off their full holdings heading into Q4. It’s worth mentioning that Michael Platt and William Reeves’s BlueCrest Capital Mgmt said goodbye to the biggest stake of the “upper crust” of funds monitored by Insider Monkey, comprising an estimated $13 million in stock, and John Burbank’s Passport Capital was right behind this move, as the fund dropped about $2 million worth. These bearish behaviors are interesting, as aggregate hedge fund interest was cut by 1 funds heading into Q4.

Let’s go over hedge fund activity in other stocks similar to Silver Wheaton Corp. (USA) (NYSE:SLW). We will take a look at ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS), StanCorp Financial Group, Inc. (NYSE:SFG), Seattle Genetics, Inc. (NASDAQ:SGEN), and Cameco Corporation (USA) (NYSE:CCJ). This group of stocks’ market values resemble SLW’s market value.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
ISIS 21 94251 -5
SFG 23 438052 14
SGEN 21 2091919 5
CCJ 21 301345 -5

As you can see these stocks had an average of 21.5 hedge funds with bullish positions and the average amount invested in these stocks was $731 million. That figure was $204 million in SLW’s case. StanCorp Financial Group, Inc. (NYSE:SFG) is the most popular stock in this table. On the other hand ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) is the least popular one with only 21 bullish hedge fund positions. Compared to these stocks Silver Wheaton Corp. (USA) (NYSE:SLW) is as less popular as ISIS. Considering that hedge funds aren’t fond of this stock in relation to other companies analyzed in this article, it may be a good idea to analyze it in detail and understand why the smart money isn’t behind this stock. This isn’t necessarily bad news. Although it is possible that hedge funds may think the stock is overpriced and view the stock as a short candidate, they may not be very familiar with the bullish thesis. In either case more research is warranted.

Page 2 of 2